Influenza A Reduction

Vivienne Mahon, Science & Quality Manager

Airmid Health Group Ltd.


To evaluate the efficacy of the NV1050 on removing Influenza A.


Testing of the NV1050 was conducted in a 28.5 m3 environmental test chamber. The chamber was preconditioned to 68±5ºF and 50±10% relative humidity prior to the commencement of the tests. For the test runs, the NV1050 was placed on the floor in the center of the chamber.

Summary of Results

The NV1050 was effective in reducing airborne Influenza A aerosols in the test chamber, reaching 99.9% airborne virus reduction within the first 10 – 20 minutes of operation at max speed.